论文部分内容阅读
目的分析并探讨肾炎康复片联合前列地尔治疗糖尿病肾病的临床疗效。方法选取2011年7月—2014年7月在该院接受治疗的糖尿病肾病患者140例,随机分为观察组与对照组,每组70例。二组患者均给予常规的支持治疗和低糖饮食治疗,将空腹血糖控制在7mmol/L以下。在此基础上,观察组给予肾炎康复片联合前列地尔的治疗方案,而对照组仅给予前列地尔药物治疗。结果观察组显效38例,有效27例,无效5例,总有效率为92.86%;对照组显效29例,有效28例,无效13例,总有效率为81.43%。二组患者治疗后各项指标与治疗前相比均有显著改善,治疗后,观察组总胆固醇、三酰甘油、尿素氮、24h尿蛋白改善程度明显优于对照组(P<0.05)。结论肾炎康复片联合前列地尔治疗糖尿病肾病的临床疗效显著,值得推广。
Objective To analyze and discuss the clinical efficacy of nephritis rehabilitation tablets combined with alprostadil in the treatment of diabetic nephropathy. Methods 140 cases of diabetic nephropathy treated in our hospital from July 2011 to July 2014 were randomly divided into observation group and control group with 70 cases in each group. Two groups of patients were given conventional supportive therapy and low-sugar diet, fasting blood glucose control in 7mmol / L or less. On this basis, the observation group was given nephritis rehabilitation tablets combined with alprostadil treatment, while the control group was given only alprostadil drug treatment. Results In the observation group, 38 cases were markedly effective, 27 cases were effective, 5 cases were ineffective, and the total effective rate was 92.86%. In the control group, 29 cases were markedly effective, 28 cases were effective and 13 cases were ineffective. The total effective rate was 81.43%. After treatment, the indexes in both groups were significantly improved compared with those before treatment. After treatment, the improvement of total cholesterol, triglyceride, urea nitrogen and 24-hour urinary protein in the observation group was significantly better than that of the control group (P <0.05). Conclusion Nephritis rehabilitation tablets combined with alprostadil treatment of diabetic nephropathy significant clinical efficacy, it is worth promoting.